AU4482996A
(en)
*
|
1995-09-22 |
1997-04-09 |
Novo Nordisk A/S |
Novel variants of green fluorescent protein, gfp
|
US6803188B1
(en)
*
|
1996-01-31 |
2004-10-12 |
The Regents Of The University Of California |
Tandem fluorescent protein constructs
|
US6593135B2
(en)
*
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
US6670449B1
(en)
|
1997-02-13 |
2003-12-30 |
Memorial Sloan-Kettering Cancer Center |
Hybrid molecules and their use for optically detecting changes in cellular microenvironments
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
ATE412050T1
(en)
*
|
1997-03-14 |
2008-11-15 |
Univ California |
FLUORESCENT PROTEIN SENSORS FOR DETECTING ANALYTES
|
US7105307B2
(en)
|
1997-08-30 |
2006-09-12 |
Cyclacel, Ltd. |
Compositions and methods for screening for modulators of enzymatic activity
|
US6881683B2
(en)
*
|
1998-02-05 |
2005-04-19 |
Asm Japan K.K. |
Insulation film on semiconductor substrate and method for forming same
|
US7090976B2
(en)
*
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
US6140132A
(en)
*
|
1998-06-09 |
2000-10-31 |
The Regents Of The University Of California |
Fluorescent protein sensors for measuring the pH of a biological sample
|
US6150176A
(en)
*
|
1998-06-09 |
2000-11-21 |
The Regents Of The University Of California |
Fluorescent protein sensors for measuring the pH of a biological sample
|
EP1102977A1
(en)
*
|
1998-08-08 |
2001-05-30 |
Imperial Cancer Research Technology Limited |
Fluorescence assay for biological systems
|
US6656696B2
(en)
|
1999-02-26 |
2003-12-02 |
Cyclacel |
Compositions and methods for monitoring the phosphorylation of natural binding partners
|
US6670144B1
(en)
|
1999-02-26 |
2003-12-30 |
Cyclacel, Ltd. |
Compositions and methods for monitoring the phosphorylation of natural binding partners
|
US6828106B2
(en)
*
|
1999-02-26 |
2004-12-07 |
Cyclacel Limited |
Methods and compositions using coiled binding partners
|
US6972182B1
(en)
*
|
1999-02-26 |
2005-12-06 |
Cyclacel, Ltd. |
Methods and compositions using coiled binding partners
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6562563B1
(en)
|
1999-11-03 |
2003-05-13 |
Mitokor |
Compositions and mehtods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
|
US7060506B2
(en)
|
2000-01-31 |
2006-06-13 |
Cyclacel, Ltd. |
Compositions and methods for monitoring the modification of modification dependent binding partner polypeptides
|
US6656700B2
(en)
*
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
US6686188B2
(en)
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
US6808874B2
(en)
|
2000-06-13 |
2004-10-26 |
Cyclacel Ltd. |
Methods of monitoring enzyme activity
|
DE60139556D1
(en)
*
|
2000-06-19 |
2009-09-24 |
Fisher Bioimage Aps |
FLUORESCENT PROTEINS
|
US20040072995A1
(en)
*
|
2000-06-19 |
2004-04-15 |
Bjorn Sara P. |
Novel fluorescent proteins
|
US6667153B1
(en)
|
2000-06-26 |
2003-12-23 |
Susan Margaret Thomas |
Composition and method for detecting mutagens
|
US20020123474A1
(en)
*
|
2000-10-04 |
2002-09-05 |
Shannon Mark E. |
Human GTP-Rho binding protein2
|
EP1409674A2
(en)
*
|
2000-10-27 |
2004-04-21 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding them
|
CA2427701A1
(en)
*
|
2000-10-30 |
2002-05-10 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
WO2002040874A1
(en)
|
2000-11-16 |
2002-05-23 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US7005511B2
(en)
|
2001-02-26 |
2006-02-28 |
The Regents Of The University Of California |
Fluorescent protein variants and methods for making same
|
JP3929250B2
(en)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
Semiconductor device
|
US7015310B2
(en)
|
2001-03-12 |
2006-03-21 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Oxidation reduction sensitive green fluorescent protein variants
|
GB0109858D0
(en)
*
|
2001-04-23 |
2001-06-13 |
Amersham Pharm Biotech Uk Ltd |
Fluorscent proteins
|
US20030044847A1
(en)
*
|
2001-05-15 |
2003-03-06 |
Sidney Pestka |
Methods for anlyzing interactions between proteins in live and intact cells
|
AU2002309989A1
(en)
*
|
2001-05-18 |
2002-12-03 |
Rigel Pharmaceuticals, Incorporated |
Directed evolution of protein in mammalian cells
|
US7354735B2
(en)
*
|
2001-05-24 |
2008-04-08 |
Hong Kong University Of Science And Technology |
Nucleic acid encoding fluorescent protein constructs and methods for detecting apoptosis
|
JP3829252B2
(en)
*
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
Fluorescent protein
|
US20040078837A1
(en)
*
|
2001-08-02 |
2004-04-22 |
Shannon Mark E. |
Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
|
US20040096880A1
(en)
*
|
2001-08-07 |
2004-05-20 |
Kmiec Eric B. |
Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
|
CA2455424A1
(en)
*
|
2001-08-07 |
2003-02-20 |
University Of Delaware |
Compositions and methods for the prevention and treatment of huntington's disease
|
US6900289B2
(en)
*
|
2001-08-22 |
2005-05-31 |
The University Of Hawaii |
Physalia fluorescent proteins
|
US20030027315A1
(en)
*
|
2001-09-24 |
2003-02-06 |
Ada Yonath |
Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
|
CA2462598A1
(en)
*
|
2001-10-01 |
2003-04-10 |
Bioimage A/S |
A method of detecting intracellular protein-protein interactions using three heterologous conjugates
|
GB0123856D0
(en)
*
|
2001-10-05 |
2001-11-28 |
Amersham Pharm Biotech Uk Ltd |
Method for determining cell cycle position
|
WO2003040312A2
(en)
*
|
2001-10-24 |
2003-05-15 |
University Of Hawaii |
Multifunctional green fluorescent protein and uses thereof
|
AU2002350039A1
(en)
*
|
2001-10-29 |
2003-05-12 |
Renovis, Inc. |
Method for isolating cell-type specific mrnas
|
US7846671B2
(en)
|
2002-01-28 |
2010-12-07 |
Bristol-Myers Squibb Company |
Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence
|
GB0207533D0
(en)
|
2002-04-02 |
2002-05-08 |
Oxford Glycosciences Uk Ltd |
Protein
|
US20050181464A1
(en)
*
|
2002-04-04 |
2005-08-18 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from bacteria
|
US7335488B2
(en)
*
|
2002-04-05 |
2008-02-26 |
The Chinese University Of Hong Kong |
Fluorescent proteins
|
CA2899360A1
(en)
|
2002-08-21 |
2004-04-08 |
Revivicor, Inc. |
Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
US7056683B2
(en)
*
|
2002-11-12 |
2006-06-06 |
Massachusetts Institute Of Technology |
Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
|
WO2004090115A2
(en)
|
2003-04-04 |
2004-10-21 |
Stratagene |
Renilla gfp mutants with increased fluorescent intensity and special shift
|
US20050037364A1
(en)
*
|
2003-08-13 |
2005-02-17 |
International Business Machines Corporation |
Techniques for recording signals
|
US20050048493A1
(en)
*
|
2003-08-27 |
2005-03-03 |
Zyomyx, Inc. |
Film layer for detection of immobilized analytes
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
BRPI0513826A2
(en)
|
2004-07-26 |
2010-06-22 |
Dow Global Technologies Inc |
process for improved protein expression through strain engineering
|
WO2006060739A2
(en)
|
2004-12-01 |
2006-06-08 |
Proteologics, Inc. |
Ubiquitin ligase assays and related reagents
|
AU2006340711C1
(en)
|
2005-04-05 |
2013-02-07 |
Allergan, Inc. |
Clostridial toxin activity assays
|
EP2949668B1
(en)
|
2005-05-18 |
2019-08-14 |
Ablynx N.V. |
Improved nanobodies tm against tumor necrosis factor-alpha
|
CA2608873C
(en)
|
2005-05-20 |
2017-04-25 |
Ablynx Nv |
Single domain vhh antibodies against von willebrand factor
|
US8362250B2
(en)
|
2005-05-24 |
2013-01-29 |
Enzo Biochem, Inc. |
Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
|
AU2006292827B2
(en)
|
2005-08-09 |
2013-02-14 |
Revivicor, Inc. |
Transgenic ungulates expressing CTLA4-IG and uses thereof
|
WO2007052102A2
(en)
*
|
2005-11-04 |
2007-05-10 |
Evrogen, Jsc |
Modified green fluorescent proteins and methods for using same
|
PL2347775T3
(en)
|
2005-12-13 |
2020-11-16 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
EP1988161B1
(en)
*
|
2006-01-26 |
2012-03-07 |
NEC Soft, Ltd. |
Method of changing fluorescence wavelength of fluoroprotein
|
JP2009530423A
(en)
*
|
2006-03-21 |
2009-08-27 |
ワイス |
Methods for preventing and treating amyloidogenic diseases
|
GB0606430D0
(en)
*
|
2006-03-31 |
2006-05-10 |
Ge Healthcare Uk Ltd |
Method for cell based assays
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
GB0624462D0
(en)
*
|
2006-12-07 |
2007-01-17 |
Ge Healthcare Ltd |
Method for determining gentoxicity
|
WO2008074839A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
EP2514767A1
(en)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
WO2008114544A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Tokyo Metropolitan Organization For Medical Research |
Probe for visualizing cell cycle
|
CN101688213A
(en)
|
2007-04-27 |
2010-03-31 |
陶氏环球技术公司 |
Be used for rapidly screening microbial hosts to identify some method at the bacterial strain of output that has improvement aspect the expressing heterologous protein and/or quality
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
CN101946171B
(en)
*
|
2007-12-14 |
2014-03-12 |
拜奥蒂乌姆股份有限公司 |
Fluorescent compounds
|
GB0800938D0
(en)
*
|
2008-01-18 |
2008-02-27 |
Ge Healthcare Uk Ltd |
Multiplex cell signalling assay
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
JP5690143B2
(en)
|
2008-02-13 |
2015-03-25 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
Continuous cell programming device
|
US20110071049A1
(en)
*
|
2008-03-12 |
2011-03-24 |
Nathaniel Heintz |
Methods and compositions for translational profiling and molecular phenotyping
|
EP2260058A2
(en)
|
2008-04-07 |
2010-12-15 |
Ablynx N.V. |
Single variable domains against the notch pathways
|
WO2009146456A1
(en)
|
2008-05-30 |
2009-12-03 |
President And Fellows Of Harvard College |
Controlled release of growth factors and signaling molecules for promoting angiogenesis
|
US20100017232A1
(en)
*
|
2008-07-18 |
2010-01-21 |
StevenDale Software, LLC |
Information Transmittal And Notification System
|
JP5654989B2
(en)
*
|
2008-07-22 |
2015-01-14 |
フィブロスタチン ソシエダ リミターダFibrostatin,Sociedad Limitada |
Goodpasture antigen binding protein and its detection
|
US9250249B2
(en)
|
2008-09-08 |
2016-02-02 |
Enzo Biochem, Inc. |
Autophagy and phospholipidosis pathway assays
|
US9334281B2
(en)
*
|
2008-09-08 |
2016-05-10 |
Enzo Life Sciences, Inc. |
Fluorochromes for organelle tracing and multi-color imaging
|
CN102257003B
(en)
|
2008-12-19 |
2017-04-05 |
埃博灵克斯股份有限公司 |
For producing the genetic immunization of the immunoglobulin for cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
JP5647222B2
(en)
|
2009-04-10 |
2014-12-24 |
アブリンクス エン.ヴェー. |
Improved amino acid sequence directed against IL-6R for the treatment of IL-6R related diseases and disorders and polypeptides comprising the same
|
WO2010120749A2
(en)
|
2009-04-13 |
2010-10-21 |
President And Fellow Of Harvard College |
Harnessing cell dynamics to engineer materials
|
US8945567B2
(en)
|
2009-06-05 |
2015-02-03 |
Ablynx N.V. |
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
|
AU2010278702C1
(en)
|
2009-07-31 |
2016-07-14 |
Forsyth Dental Infirmary For Children |
Programming of cells for tolerogenic therapies
|
US8741591B2
(en)
|
2009-10-09 |
2014-06-03 |
The Research Foundation For The State University Of New York |
pH-insensitive glucose indicator protein
|
US8658434B2
(en)
*
|
2009-10-28 |
2014-02-25 |
Biotium, Inc. |
Fluorescent pyrene compounds
|
EP2507262A1
(en)
|
2009-11-30 |
2012-10-10 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
DE102010009445A1
(en)
|
2010-02-25 |
2011-08-25 |
Universitätsklinikum Jena, 07743 |
Expression vector comprising promoter, interfaces to insert use-specific gene sequence and genetic information expressing enzyme, useful to express peptide-inhibited small interfering RNA cleaving enzyme, preferably protease or peptidase
|
EP2542230A4
(en)
|
2010-03-05 |
2013-08-28 |
Harvard College |
Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
|
EP2585053A4
(en)
|
2010-06-25 |
2014-02-26 |
Harvard College |
Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
|
EP3202415B1
(en)
|
2010-06-30 |
2021-12-08 |
Compugen Ltd. |
Fusion protein comprising a c1orf32 polypeptide and one or more domains of an immunoglobulin heavy chain constant region for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders.
|
AU2011289579B2
(en)
|
2010-08-10 |
2016-11-17 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
KR20130100290A
(en)
|
2010-08-30 |
2013-09-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Shear controlled release for stenotic lesions and thrombolytic therapies
|
EP2616100B1
(en)
|
2010-09-17 |
2016-08-31 |
Compugen Ltd. |
Compositions and methods for treatment of drug resistant multiple myeloma
|
CA2813751C
(en)
|
2010-10-06 |
2019-11-12 |
President And Fellows Of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
US9603894B2
(en)
|
2010-11-08 |
2017-03-28 |
President And Fellows Of Harvard College |
Materials presenting notch signaling molecules to control cell behavior
|
AU2012219582A1
(en)
|
2011-02-21 |
2013-08-22 |
Fibrostatin S.L. |
Methods for treating and diagnosing disease
|
US10647959B2
(en)
|
2011-04-27 |
2020-05-12 |
President And Fellows Of Harvard College |
Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
|
AU2012249456A1
(en)
|
2011-04-28 |
2013-10-31 |
President And Fellows Of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
EP2709450A4
(en)
|
2011-05-20 |
2015-04-15 |
Benjamin Wolozin |
Identification of compounds that disperse tdp-43 inclusions
|
AU2012261848B2
(en)
|
2011-06-03 |
2017-06-15 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
KR20140068087A
(en)
|
2011-08-23 |
2014-06-05 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Peptide nanoparticles and uses thereof
|
GB201121565D0
(en)
|
2011-12-15 |
2012-01-25 |
Fundaci Privada Ct De Regulaci Gen Mica Crg |
Engineering fluorescent proteins for enhanced fret and uses thereof
|
GB201121570D0
(en)
|
2011-12-15 |
2012-01-25 |
Fundaci Privada Ct De Regulaci Gen Mica Crg |
Methods for producing engineered fluorescent proteins for enhanced fret, products and uses thereof
|
EP4108782B1
(en)
|
2011-12-22 |
2023-06-07 |
President and Fellows of Harvard College |
Compositions and methods for analyte detection
|
WO2013130808A1
(en)
|
2012-02-29 |
2013-09-06 |
D.E. Shaw Research, Llc |
Methods for screening voltage gated proteins
|
CA2870309C
(en)
|
2012-04-16 |
2024-02-20 |
President And Fellows Of Harvard College |
Mesoporous silica compositions for modulating immune responses
|
JP6388575B2
(en)
|
2012-06-06 |
2018-09-12 |
アメリカ合衆国 |
Kit for detecting and monitoring endocrine disrupting substances (EDC)
|
CN104684584A
(en)
|
2012-07-02 |
2015-06-03 |
费卜卢斯坦丁公司 |
Gpbp-1 inhibition and its therapeutic use
|
US9682123B2
(en)
|
2013-12-20 |
2017-06-20 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating metabolic disease
|
SG10202010936RA
(en)
|
2014-02-21 |
2020-12-30 |
Ecole Polytecnique Fed De Lausanne Epfl Epfl Tto |
Glycotargeting therapeutics
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
CA2945945C
(en)
|
2014-04-15 |
2023-10-03 |
The Regents Of The University Of California |
Bi-terminal pegylated integrin-binding peptides and methods of use thereof
|
WO2015168379A2
(en)
|
2014-04-30 |
2015-11-05 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
WO2016007886A1
(en)
|
2014-07-11 |
2016-01-14 |
Northwestern University |
Yeast-based biosensor
|
US20170369474A1
(en)
|
2014-12-05 |
2017-12-28 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use
|
CA2969756A1
(en)
|
2014-12-05 |
2016-06-09 |
Aquinnah Pharmaceuticals, Inc. |
Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases
|
US11786457B2
(en)
|
2015-01-30 |
2023-10-17 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
CN107708756A
(en)
|
2015-04-10 |
2018-02-16 |
哈佛学院院长等 |
Immunocyte acquisition equipment and its preparation and application
|
AU2016291846B2
(en)
|
2015-07-13 |
2022-05-26 |
Compugen Ltd. |
HIDE1 Compositions and Methods
|
CA2997947A1
(en)
|
2015-09-09 |
2017-03-16 |
The Trustees Of Columbia University In The City Of New York |
Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
|
CA3001857A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
US20180312534A1
(en)
|
2015-10-16 |
2018-11-01 |
Invictus Oncology Pvt. Ltd. |
Fluorescent anticancer platinum drugs
|
EP3411475A4
(en)
|
2016-02-06 |
2019-09-11 |
President and Fellows of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
CN115305229A
(en)
|
2016-07-13 |
2022-11-08 |
哈佛学院院长等 |
Antigen presenting cell mimetic scaffolds and methods of making and using same
|
US11840569B2
(en)
|
2016-11-16 |
2023-12-12 |
Ablynx N.V. |
T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
EP3638296A1
(en)
|
2017-06-16 |
2020-04-22 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
WO2019136421A1
(en)
*
|
2018-01-08 |
2019-07-11 |
Lucidicor Inc. |
Fluorescent protein biosensor for detection of kinase activity
|
WO2019162521A1
(en)
|
2018-02-26 |
2019-08-29 |
Ablynx Nv |
Improved nucleotide sequences encoding peptide linkers
|
BR102019017792A2
(en)
|
2019-08-27 |
2021-11-16 |
Fundação Oswaldo Cruz |
PROTEIN RECEPTACLE, METHOD FOR PRODUCTION OF THE RECEPTACLE, METHOD OF IDENTIFICATION OF PATHOGENS OR DISEASE DIAGNOSIS, AND, USE OF THE RECEPTACLE
|
EP4136457A1
(en)
|
2020-04-17 |
2023-02-22 |
Regeneron Pharmaceuticals, Inc. |
Detection assays for coronavirus neutralizing antibodies
|
CN113265428B
(en)
*
|
2021-06-11 |
2023-03-14 |
东北林业大学 |
Detection system for constructing copper change in living cells by utilizing metallothionein and application
|
IL310330A
(en)
|
2021-07-30 |
2024-03-01 |
Confo Therapeutics N V |
Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
|